203 related articles for article (PubMed ID: 22937156)
21. Expression of multidrug resistance genes in normal and cancer stem cells.
Shervington A; Lu C
Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
[TBL] [Abstract][Full Text] [Related]
22. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
[TBL] [Abstract][Full Text] [Related]
23. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
Choy W; Nagasawa DT; Trang A; Thill K; Spasic M; Yang I
Neurosurg Clin N Am; 2012 Jul; 23(3):391-405. PubMed ID: 22748652
[TBL] [Abstract][Full Text] [Related]
24. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2.
Iida H; Suzuki M; Goitsuka R; Ueno H
Int J Oncol; 2012 Jan; 40(1):71-9. PubMed ID: 21947321
[TBL] [Abstract][Full Text] [Related]
26. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
Liu Q; Nguyen DH; Dong Q; Shitaku P; Chung K; Liu OY; Tso JL; Liu JY; Konkankit V; Cloughesy TF; Mischel PS; Lane TF; Liau LM; Nelson SF; Tso CL
J Neurooncol; 2009 Aug; 94(1):1-19. PubMed ID: 19468690
[TBL] [Abstract][Full Text] [Related]
27. Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1.
Bageritz J; Puccio L; Piro RM; Hovestadt V; Phillips E; Pankert T; Lohr J; Herold-Mende C; Lichter P; Goidts V
Cell Death Differ; 2014 Jun; 21(6):929-40. PubMed ID: 24531536
[TBL] [Abstract][Full Text] [Related]
28. CD133 and BMI1 expressions and its prognostic role in primary glioblastoma.
Sibin MK; Lavanya CH; Bhat DI; Rao N; Geethashree N; Vibhuti W; Chetan GK
J Genet; 2015 Dec; 94(4):689-96. PubMed ID: 26690524
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.
Metellus P; Nanni-Metellus I; Delfino C; Colin C; Tchogandjian A; Coulibaly B; Fina F; Loundou A; Barrie M; Chinot O; Ouafik L; Figarella-Branger D
Ann Surg Oncol; 2011 Oct; 18(10):2937-45. PubMed ID: 21479688
[TBL] [Abstract][Full Text] [Related]
30. Novel gene expression model for outcome prediction in paediatric medulloblastoma.
Zakrzewska M; Grešner SM; Zakrzewski K; Zalewska-Szewczyk B; Liberski PP
J Mol Neurosci; 2013 Oct; 51(2):371-9. PubMed ID: 23649504
[TBL] [Abstract][Full Text] [Related]
31. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Ioue Y; Miki C; Kusunoki M
Ann Surg Oncol; 2009 Dec; 16(12):3488-98. PubMed ID: 19657699
[TBL] [Abstract][Full Text] [Related]
32. Sox2-positive dermal papilla cells specify hair follicle type in mammalian epidermis.
Driskell RR; Giangreco A; Jensen KB; Mulder KW; Watt FM
Development; 2009 Aug; 136(16):2815-23. PubMed ID: 19605494
[TBL] [Abstract][Full Text] [Related]
33. Expression and regulation of AC133 and CD133 in glioblastoma.
Campos B; Zeng L; Daotrong PH; Eckstein V; Unterberg A; Mairbäurl H; Herold-Mende C
Glia; 2011 Dec; 59(12):1974-86. PubMed ID: 21901757
[TBL] [Abstract][Full Text] [Related]
34. Expression analysis of stem cell-related genes reveal OCT4 as a predictor of poor clinical outcome in medulloblastoma.
Rodini CO; Suzuki DE; Saba-Silva N; Cappellano A; de Souza JE; Cavalheiro S; Toledo SR; Okamoto OK
J Neurooncol; 2012 Jan; 106(1):71-9. PubMed ID: 21725800
[TBL] [Abstract][Full Text] [Related]
35. [Adherent culture of CD133+ cells in glioblastomas and expression of ADLH1].
Wang P; Mao Q; Wang X; Chen MN; Gan LA; Liu YH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):413-6. PubMed ID: 21827011
[TBL] [Abstract][Full Text] [Related]
36. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.
Ying M; Wang S; Sang Y; Sun P; Lal B; Goodwin CR; Guerrero-Cazares H; Quinones-Hinojosa A; Laterra J; Xia S
Oncogene; 2011 Aug; 30(31):3454-67. PubMed ID: 21383690
[TBL] [Abstract][Full Text] [Related]
37. Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1.
Velpula KK; Dasari VR; Tsung AJ; Dinh DH; Rao JS
Oncotarget; 2011 Dec; 2(12):1028-42. PubMed ID: 22184289
[TBL] [Abstract][Full Text] [Related]
38. Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties.
Tchoghandjian A; Baeza-Kallee N; Beclin C; Metellus P; Colin C; Ducray F; Adélaïde J; Rougon G; Figarella-Branger D
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S608-19. PubMed ID: 21989663
[TBL] [Abstract][Full Text] [Related]
39. Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo.
deCarvalho AC; Nelson K; Lemke N; Lehman NL; Arbab AS; Kalkanis S; Mikkelsen T
Stem Cells; 2010 Feb; 28(2):181-90. PubMed ID: 19937755
[TBL] [Abstract][Full Text] [Related]
40. Identification of a cancer stem cell in human brain tumors.
Singh SK; Clarke ID; Terasaki M; Bonn VE; Hawkins C; Squire J; Dirks PB
Cancer Res; 2003 Sep; 63(18):5821-8. PubMed ID: 14522905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]